01046nam0 2200277 450 00003437320130206124418.0978-3-527-32418-720130206d2010----km-y0itaa50------baengGreen chemistry in the pharmaceutical industryedited by Peter J. Dunn, Andrew S. Wells and Michael T. WilliansWeinheimWiley2010XVIII, 370 p.ill.25 cm.Industria farmaceuticaAspetti ambientali338.476151(22. ed.)Industria farmaceuticaDunn,Peter J.Wells,Andrew S.Williams,Michael T.ITUniversità della Basilicata - B.I.A.RICAunimarc000034373Green chemistry in the pharmaceutical industry96249UNIBASSCIENZETTM3020130206BAS011244BAS01BAS01BOOKBASA2Polo Tecnico-ScientificoDIDDidatticaPTS.s4.p45.5111729T11172920130206XL98Consultazione01449nam 2200385 a 450 991069830070332120051011112024.0(CKB)4970000000030481(OCoLC)61903066(EXLCZ)99497000000003048120051011d2005 ua 0engurmn|---|||||txtrdacontentcrdamediacrrdacarrierFinancial audit[electronic resource] the Pension Benefit Guaranty Corporation's fiscal year 2004 management representation letter on its financial statementsWashington, D.C. :U.S. Government Accountability Office,[2005]18 pages digital, PDF fileTitle from title screen (viewed on Sept. 21, 2005)."July 22, 2005."Paper version available from: U.S. Government Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548."GAO-05-610R."Includes bibliographical references.Financial AuditFinancial statements, ConsolidatedUnited StatesAuditingFinancial statements, ConsolidatedAuditing.Engel Gary T1381403United States.Government Accountability Office.GPOGPODOCUMENT9910698300703321Financial audit3423983UNINA